Navigation Links
Tests to catch the makers of dangerous 'legal high' designer drugs
Date:10/13/2011

Urgently needed tests which could help identify the manufacturers of designer 'legal high' drugs are being developed in research led at the University of Strathclyde in Glasgow.

The drugs, known by names such as 'ivory wave' and NRG-1" and sold labelled as bath salts, plant food and incense, mimic the effects of illegal drugs such as amphetamine, cocaine and ecstasy. Although these so-called 'designer drugs' can be dangerous, many have not yet been made illegal and are difficult to detect with current drug tests.

A means of potentially tracing the source of the raw materials, and consequently providing information as to who is making the 'bath salts,' is being developed by scientists at Strathclyde and The James Hutton Institute.

The bath salts drug can cause euphoria, paranoia, anxiety and hallucinations. It often contains mephedrone, a synthetic compound structurally related to methcathinone, which is found in Khat - a plant which, like mephedrone itself, is illegal in many countries.

The bath salts drug is labelled as being not for human consumption and is not illegal in the UK but its import has been banned. The term 'bath salts' is used by those who sell the drug as a way of circumventing legislation when supplying it.

The researchers developing tests for the drug are using a technique known as isotope ratio mass spectrometry (IRMS) to reveal the course of a drug's manufacture.

The research is being carried out by Dr Oliver Sutcliffe, at the Strathclyde Institute of Pharmacy and Biomedical Sciences, and Professor Niamh Nic Daeid and Dr Katy Savage at the Centre for Forensic Science in the Department of Pure and Applied Chemistry, in collaboration with Dr Wolfram Meier-Augenstein at The James Hutton Institute.

Dr Sutcliffe said: "The legal status of designer drugs varies around the world but they present many dangers to users and these are borne out by the Home Office's decision to ban the import of 'bath salts.'

"The new method we have used has enabled us to work backwards and trace the substances back to their starting materials. IRMS measures the relative amounts of an element's different forms- it is successful because these relative amounts are transferred like a fingerprint through the synthesis of the drug."


'/>"/>
Contact: Corporate Comms
corporatecomms@strath.ac.uk
44-014-154-82370
University of Strathclyde
Source:Eurekalert  

Related medicine news :

1. Direct-to-Consumer Gene Tests Cause Little Anxiety: Study
2. Blood tests may hold clues to pace of Alzheimers disease progression
3. New research shows $6.7 billion spent on unnecessary tests and treatments in one year
4. Annual Pap Tests Often Ordered But Unneeded: Study
5. Many Heart Patients Anemic After Too Many Blood Tests in Hospital
6. Frequent Tests Help Track Progression of Glaucoma, Study Finds
7. Abnormal liver tests associated with increased death rates in people over 75
8. Successful lab tests on a potential vaccine for heroin addiction
9. False negative tests in breast cancer may lead to wrong drug choice
10. Noninvasive liver tests may predict hepatitis C patient survival
11. Validity of Baseline Concussion Tests Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tests to catch the makers of dangerous 'legal high' designer drugs
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Florida Hospital ... Lightning take on the St. Louis Blues at the Amalie Arena. The puck drops ... inflatable, walk-through heart exhibit, the MEGA Heart, prior to the game. The MEGA Heart ...
(Date:2/11/2016)... ... , ... The president released a FY 2017 budget request on Tuesday that ... the cost burden to military beneficiaries. , MOAA’s president, retired Air Force Lt. ... including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We were ...
(Date:2/11/2016)... Petersburg, FL (PRWEB) , ... February 11, 2016 ... ... providers and advocates will discuss how to improve care by making data on ... pediatric heart disease. The Summit on Transparency and Public Reporting of Pediatric and ...
(Date:2/11/2016)... ... February 11, 2016 , ... Atlantic Information Services, ... Benefit Model: A Case Study for Plans and Purchasers.” Executives from Intel Corp. ... with Intel on value-based health benefits program Connected Care, will discuss the challenges ...
(Date:2/11/2016)... ... 11, 2016 , ... "What holds you back from ... a question as a challenge for his readers to examine the full scale ... (published by Partridge Singapore), Clarke explores the subject with more depth, revealing time-honored ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... de fevereiro de 2016  A Proliant Biologicals ... de soroalbumina bovina (BSA -- Bovine Serum ... na Ilha Norte da Nova Zelândia, em Feilding. ... na fábrica da Proliant nos EUA, localizada em ... e instalação dos equipamentos foram feitos de forma ...
(Date:2/11/2016)... Transformational M&A achieved through NPS and Dyax acquisitions and the ... achieved through NPS and Dyax acquisitions and the announced combination ... through NPS and Dyax acquisitions and the announced combination with ... robust pipeline in Shire , s history   ... pipeline in Shire , s history   ...
(Date:2/11/2016)... , February 11, 2016 Breast Cancer ... the Asia-Pacific (APAC) breast cancer market ... $3.4 billion by 2021, at a Compound Annual Growth Rate ... Asia-Pacific Markets to 2021 - states that the ... considerable expansion from $1.9 billion in 2014 to $3.4 billion ...
Breaking Medicine Technology: